Iams Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56,963
Closed -$2.9M 196
2025
Q4
$2.9M Buy
56,963
+7,685
+16% +$393K 1.05% 21
2025
Q3
$2.73M Buy
49,278
+12,617
+34% +$739K 1.1% 24
2025
Q2
$2.53M Sell
36,661
-279
-0.8% -$19K 1.16% 21
2025
Q1
$2.57M Buy
36,940
+13,168
+55% +$1.09M 1.17% 21
2024
Q4
$2.04M Buy
23,772
+6,769
+40% +$732K 0.93% 32
2024
Q3
$2.02M Buy
17,003
+1,144
+7% +$153K 0.99% 29
2024
Q2
$2.26M Sell
15,859
-335
-2% -$44.4K 1.24% 17
2024
Q1
$1.97M Sell
16,194
-2,430
-13% -$289K 1.2% 19
2023
Q4
$1.93M Sell
18,624
-2,184
-10% -$216K 1.25% 17
2023
Q3
$1.89M Buy
+20,808
New +$1.83M 1.31% 18
2023
Q2
Sell
-17,902
Closed -$1.46M 200
2023
Q1
$1.41M Buy
17,902
+2,244
+14% +$159K 1.17% 17
2022
Q4
$1.06M Buy
+15,658
New +$918K 1.08% 19

Other funds holding NVO

Iams Wealth Management's NVO Position: Q1 2026 in Review

Iams Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 56,963 shares — an estimated $2.9M sold.

Iams Wealth Management first reported a position in NVO in Q4 2022 and held it in 12 quarters. The position peaked at $2.9M in Q4 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Iams Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Iams Wealth Management sold 56,963 Novo Nordisk shares in Q1 2026, an estimated $2.9M.
  • Iams Wealth Management first reported a position in Novo Nordisk in Q4 2022 and held it in 12 quarters.
  • Iams Wealth Management's Novo Nordisk position peaked at $2.9M in Q4 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Iams Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.